Skip to content
Top Globe News – Lifestyle
Author:
Mineralys Therapeutics, Inc.
Mineralys Therapeutics Announces FDA Acceptance of NDA for Lorundrostat for Treatment of Adults with Hypertension and Topline Explore-OSA Trial Results
March 9, 2026
←
Previous Page
1
2
3